UroGen Pharma Ltd logo

UroGen Pharma Ltd

NEW
STU:UR8 (USA)  
€ 37.26 -0.13 (-0.35%) Sep 8
At Loss
Market Cap:
€ 1.84B ($ 2.14B)
Enterprise V:
€ 1.92B ($ 2.23B)
Volume:
0
Avg Vol (2M):
545.00
Trade In:

UroGen Pharma Ltd (STU:UR8) Dividend

UroGen Pharma Ltd (STU:UR8) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -27.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:UR8 Dividend

Does UroGen Pharma Ltd (STU:UR8) pay a dividend?

UroGen Pharma Ltd (STU:UR8) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't UroGen Pharma Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. UroGen Pharma Ltd has returned capital to shareholders via buybacks at a rate of -27.9% over the past 3 years.

What are dividend-paying alternatives to UroGen Pharma Ltd?

For dividend-paying alternatives in UroGen Pharma Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.